Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Teleflex says peer-reviewed study shows 70% lower CLABSI hazard with Arrowg+ard technology
Teleflex said a peer-reviewed study in the American Journal of Infection Control found CVCs protected with Arrowg+ard technology were associated with a 70% lower hazard of CLABSI over 30 days. The study covered 1,750 critically ill patients across six hospitals in four countries.
Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the publication of its latest peer-reviewed study in the American Journal of Infection Control demonstrating that Central Venous Catheters (CVCs) protected with Arrowg+ard™ Technology were associate…